Leading BiologyLeading BiologyLeading Biology posted this:
Business Development Manager at Leading Biology
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
A Novel Therapeutic Approach Targeting Coronavirus Replication-Essential RNAs by OligonucleotidesA Novel Therapeutic Approach Targeting Coronavirus Replication-Essential RNAs by Oligonucleotides. The research team plans to develop a drug to inhibit human SARS-CoV-2 replication. They will use comparative genomics to detect conserved regions within the coronavirus family, and within human CoV-19 population, in order to identify essential genes that can be targeted to inhibit the virus replication. Project ID : 47-2020-10912
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
The Use of Chip Scale Photonics for the Advanced, and Efficient Detection of VirusesThe Use of Chip Scale Photonics for the Advanced, and Efficient Detection of Viruses Chip scale photonics technology is developing rapidly for diverse applications, from communication and computation to various types of sensing. The Levy group has pioneered diverse advanced chip scale photonic technologies, including for example low loss waveguides, high Q resonators, cutting edge filtering capabilities, integration of active and passive device on chip, and the manufacturing of hybrid chips bringing together microfluidics and photonic devices. Project ID : 47-2020-10886
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
High-Throughput Sequencing Methods to Test SamplesHighly parallel test for the presence of SARS-CoV-2 The currently used test for SARS-CoV2 virus uses molecular methods for detecting the presence of viral RNA sequences in subject samples. This is the approved gold standard in the field. The current application of this test requires several cumbersome steps that are labor intensive and require non-trivial reagents (which are becoming a global bottleneck). It is clear that during the next stage of managing the COVID19 pandemic, large scale testing will be needed. Project ID : 47-2020-10893
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Novel Activating Antibodies for Viral TreatmentNovel Activating Antibodies for Viral Treatment Various pathogens (bacteria and viruses as well) bind to specific cell adhesion molecule in order to inhibit the immune response and/or to infect the host cells. However,upon binding and induction/activation, the cell adhesion molecule suppresses virus production by an SHP2-dependent process which involves also suppression of mTOR-mediated protein biosynthesis. Project ID : 47-2020-10898
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Plant-based Diagnostic Kit to Detect Sick and Recovered SARS-CoV-2 Virus PatientsGenetically modified plant systems that allow identification of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies Applications Preventing the spread of the epidemic Restoring economic activity by returning immune-positive, symptomless people to work Features System can be rapidly reproduced through seeds Essentially unlimited quantities, extremely inexpensive Can be used in any environment No need for special machinery Adaptable to other diseases Project ID : 47-2020-10883
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19 We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time. Our method is based on a kit which identifies specifically the viral RNA biomarker. The test is characterized by reliability, sensitivity, rapid (not more than 10-15 minutes), low toxicity and reasonable cost. Project ID : 47-2020-10881
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Systematic Computational Drug Repositioning to Treat COVID-19Systematic Computational Drug Repositioning to Treat COVID-19 The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery & repositioning. Using advanced comparative genomic, and data integration, our lab has been developing a state-of-the-art AI algorithm which maps drug and food supplements that are useful in treating diseases and improving health conditions. To create this algorithm, we have been integrating and analyzing massive amounts of genomic data from 1,600 genomes, 14 thousand compounds, 20,000 human genes, and a comprehensive database of phenotypic data. Project ID : 47-2020-10880
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Screening of Drugs to Inhibit Viral InfectionsOur group has published a lot of work on the SARS Coronavirus. We were the first to characterize an important protein in the virus that has a very unusual structure and sequence (E protein). Moreover, this protein was unique to SARS and was not found in any other Coronavirus. Now importantly, the new 2019 Coronavirus has a very similar protein! Project ID : 47-2020-10879
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget
Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Pepper Genome Editing-Cas9 Stable TransformationAlexander (Sasha) Vainstein - Pepper Genome Editing-Cas9 Stable Transformation (TTM# 13921) - The researcher has developed a protocol for successfully transforming sweet and hot pepper varieties to stably express the Cas9 endonuclease of the CRISPR gene editing tool. To date, no other research group has described Cas9 gene edited pepper plants. The researcher’s Cas9-pepper lines were used for genome editing via virus-driven trans-acting guides–for all the chosen target genes/traits. This innovation will allow breeders to enhance their exhisiting pepper varieties with novel traits. Furthermore, after back-crossing the lines the breeder will be able to remove the Cas9 gene leaving behind only the gene-edited pepper varieties. These resulting lines may be considered Non-GMO in certain geographies. By combining this technology with the MemoGene TTM#1705, the breeder/researcher may screen many phenotypes when transforming a plethora of guide RNAs. IP Position: Know-How Yissum Online: http://www.yissum.co.il/technologies/project/13921 Project ID : 47-2020-13921
Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
High Throughput Screening of Antimicrobial Agents Using MicrofluidicsYonatan is a Phytopathology expert using microfluidics system to do high throughput screening of libraries to identify antimicrobial agents which can be either chemical or biological (proteins or bacteria). Yonatan is testing pathogens sensitivity against combinations of bacteria and chemical agents from the libraries using the high-throughput microfluidics system. When Potential Producer, Potential Inducer have a combined affect on a Pathogen target (killing) efficiency become of interest. This is because in nature a single bacteria species is susceptible to environmental stresses but when combined with helper bacteria they support each other synergistically. Project ID : 47-2019-10825 Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Fish feed additive to boost spawning productionFish feed additive to boost spawning production Project ID : 47-2019-10823
